Drugs / NorditropinSimplex
last change Jul 2010 re-read 3 minutes ago

NorditropinSimplex

Protein / enzyme biologic

Developed for
fetal growth restriction
Investigated by
Pfizer · Rabin Medical Center

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00522743 May 2005 → Jul 2010 fetal growth restriction Rabin Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NorditropinSimplex “All subjects will be treated with NorditropinSimplex at a dosage of 100mcg/kg/d.” NCT00522743 ↗
Modality Protein / enzyme biologic “growth hormone” NCT00522743 ↗